pexels stein egil liland 3374210

Value-Based Pharma R&D Productivity: Is There A Scalable Model?

IN VIVO, October 2014 The superior R&D and growth performance of companies like Celgene, Gilead, or Biogen can be attributed to a number of factors such as the size of the R&D budget, a high degree of portfolio focus, a good mixture of internal and external innovation sourcing, but most importantly a strong culture, leadership, and the ability to attract the right people.

Discover Other Articles

Discover Other Articles